Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

NIRvana Pharmaceuticals Inc
Profile last edited on: 1/24/13      CAGE: 484G7      UEI:

Business Identifier: Organic Derivatives and Substituted Compounds
Year Founded
2005
First Award
2007
Latest Award
2008
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

107 Weslyn Trace Drive
Durham, NC 27703
Location: Single
Congr. District: 01
County: Durham

Public Profile

NIRvana Pharmaceuticals Inc is a biotechnology company focused on diagnostic, therapeutic and theranostic applications of novel light activated molecules

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$300,000
Phase II Dollars
$299,692
Total Awarded
$599,692

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2008 2 NIH $599,692
Project Title: Stable cationic bacteriochlorins for antimicrobial photodynamic therapy

Key People / Management

  Jonathan Sidney Lindsey

Company News

There are no news available.